|
544889 SYMBIOTEC Group (B) 09 Sep,10:59
1112.20
18.05 (1.65%)
HOW HOT IS THIS STOCK?
Last 15 days data © Rediff.com Add to Watchlist
|
BSE | NSE
 ZoomRefreshDay
Wk
Mn
6Mn
Yr
|
Invest & Trade in SYMBIOTEC on dhan
2 min read
54 minutes ago
1 min read
2 hours ago
2 min read
54 minutes ago
1 min read
2 hours ago
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 563.59 | 633.85 | 622.86 | 531.19 | 527.77 |
| Operating profit | 79.47 | 104.20 | 201.50 | 118.21 | 94.89 |
| Interest | 7.42 | 1.97 | 5.65 | 9.44 | 16.98 |
| Gross profit | 84.42 | 107.88 | 204.86 | 111.95 | 82.77 |
| EPS (Rs) | -4.14 | 11.29 | 24.79 | 13.26 | 8.43 |
1 min read
3 minutes ago
2 min read
14 minutes ago
Q: What is the current share price of Symbiotec Pharmalab Ltd.?
A: The current share price of Symbiotec Pharmalab Ltd. is ₹ 1112.20 (for BSE as on 09 Sep,10:59). The 52-week range is ₹ 1,173.80 - 933.80. Prices are updated based on live market data.
Q: What is the market capitalization of Symbiotec Pharmalab Ltd.?
A: Symbiotec Pharmalab Ltd. has a market capitalization of ₹ 7,029.11 Cr, making it a company.
Q: What is the PE ratio of Symbiotec Pharmalab Ltd.?
A: The Price-to-Earnings (PE) ratio of Symbiotec Pharmalab Ltd. is -264.04, indicating its valuation relative to earnings.
Q: Is Symbiotec Pharmalab Ltd. a good investment?
A: Symbiotec Pharmalab Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.
Q: What are the latest financial results of Symbiotec Pharmalab Ltd.?
A: Symbiotec Pharmalab Ltd. has reported its latest annual results with revenue of ₹ 563.59 and net profit/loss of ₹ -22.66.
